-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
-
Summary
-
Regencell Bioscience Holdings Ltd quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2019 to Q2 2024.
- Regencell Bioscience Holdings Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2024 was $3.47M, a 19.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)